BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5474230)

  • 21. New possibilities in the treatment of urinary tract infections.
    Leigh DA
    J Chemother; 1989 Jul; 1(4 Suppl):840-2. PubMed ID: 16312663
    [No Abstract]   [Full Text] [Related]  

  • 22. Aztreonam versus cefamandole in the treatment of urinary tract infections.
    Giamarellou H; Koratzanis G; Kanellakopoulou K; Galanakis N; Papoulias G; el Messidi M; Daikos G
    Chemioterapia; 1984 Apr; 3(2):127-31. PubMed ID: 6543431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Norfloxacin in acute urinary tract infections.
    Deaney NB; Vogel R; Vandenburg MJ; Currie WJ
    Practitioner; 1984 Jan; 228(1387):111-7. PubMed ID: 6229726
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical and experimental findings on the use of pristinamycine in staphylococcal infections].
    Pagano PG; Büchi G; Varese D; Sulotto F
    Clin Ter; 1970 Mar; 52(6):525-45. PubMed ID: 5452997
    [No Abstract]   [Full Text] [Related]  

  • 25. Augmentin therapy in the treatment of urinary tract infections in general practice.
    Abbas AM; Goel PK; Venkit N; Gowers E
    Br J Clin Pract; 1984 Feb; 38(2):49-51. PubMed ID: 6704296
    [No Abstract]   [Full Text] [Related]  

  • 26. [N1-N1-diethyleniminobiguanide-methyl-tetracycline in various bacterial diseases of the urinary tract].
    Pannella A; Ruozi P
    Minerva Urol; 1969; 21(3):75-84. PubMed ID: 5398310
    [No Abstract]   [Full Text] [Related]  

  • 27. Single-dose therapy of symptomatic urinary tract infections in women.
    Knight AL
    J Iowa Med Soc; 1982 Sep; 72(9):376-8. PubMed ID: 7175247
    [No Abstract]   [Full Text] [Related]  

  • 28. [Evaluation of a new antibiotic, cephaloridine, in urinary infections].
    García AE
    Prensa Med Argent; 1965 Sep; 52(33):1920-3. PubMed ID: 5847586
    [No Abstract]   [Full Text] [Related]  

  • 29. Cefotaxime in a single daily dose in lower urinary tract infections.
    Peralta S; Affronti M; Malta R; Delle Vedove G; Pirrotta P; Rotondo G; Paternostro D; Rini GB; Di Rosa S
    J Chemother; 1989 Jul; 1(4 Suppl):847-8. PubMed ID: 16312666
    [No Abstract]   [Full Text] [Related]  

  • 30. [Infectiology of the urogenital tract. 4: Quality assurance--antibiotic selection in uncomplicated urinary tract infections].
    Naber KG
    Fortschr Med; 1997 May; 115(15):38-42. PubMed ID: 9289477
    [No Abstract]   [Full Text] [Related]  

  • 31. [Standardization of drug evaluation in the treatment of urinary tract infections].
    Ohkoshi M
    Nihon Rinsho; 1986 Dec; 44(12):2578-81. PubMed ID: 3820638
    [No Abstract]   [Full Text] [Related]  

  • 32. [Results of tobramycin in the treatment of urinary infections].
    Socquet Y
    Acta Urol Belg; 1977 Jul; 45(3):282-8. PubMed ID: 899982
    [No Abstract]   [Full Text] [Related]  

  • 33. Is an initial small-spectrum antibiotic regimen safe in fulminant hepatic failure?
    Clemmesen J; Larsen F; Rasmussen A; Hansen B
    Transplant Proc; 1995 Dec; 27(6):3505. PubMed ID: 8540071
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study of doxycycline in urinary infections].
    Schulman CC
    Acta Urol Belg; 1969 Jul; 37(3):322-7. PubMed ID: 5367798
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of antibacterial preparations in general practice. III. Treatment of patients with urinary infections].
    Mabeck CE
    Ugeskr Laeger; 1981 Mar; 143(14):871-3. PubMed ID: 7292660
    [No Abstract]   [Full Text] [Related]  

  • 36. [Severe gram-negative urinary infections].
    Vittecoq D; Modai J
    Rev Prat; 1983 Jan; 33(3):113-6. PubMed ID: 6682571
    [No Abstract]   [Full Text] [Related]  

  • 37. Adjustment for antibiotic exposure level in catheter-associated urinary tract infections.
    Utsumi M; Yamada M; Nishi I; Nabetani Y; Asari S; Tomono K; Makimoto K
    J Hosp Infect; 2008 Jun; 69(2):192-4. PubMed ID: 18439713
    [No Abstract]   [Full Text] [Related]  

  • 38. Kasugamycin treatment of Pseudomonas infection of the urinary tract.
    Ichikawa T
    Antimicrob Agents Chemother (Bethesda); 1965; 5():758-64. PubMed ID: 5883495
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of the efficacy and safety of isepamicin in the treatment of various bacterial infections.
    Petrikkos G; Giamarellou H; Tsagaraki C; Pefanis A
    J Chemother; 1995 Jun; 7 Suppl 2():161-4. PubMed ID: 8622106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and clinical evaluation of ofloxacin in urinary tract infection and enteric fever.
    Tanphaichitra D; Srimuang S
    J Chemother; 1989 Jul; 1(4 Suppl):853-4. PubMed ID: 16312669
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.